[Prediction of high risk group of patients with hepatitis-C-virus type liver cirrhosis developing to liver neoplasm].
Tarao
K
K
Shimizu
A
A
Okawa
S
S
Tamai
S
S
D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000209:etiology*; D006526:Hepatitis C / Q000150:complications* / Q000473:pathology; D006801:Humans; D008099:Liver / Q000166:cytology; D008103:Liver Cirrhosis / Q000150:complications* / Q000473:pathology; D008113:Liver Neoplasms / Q000209:etiology*; D011237:Predictive Value of Tests; D018570:Risk Assessment; D000509:alpha-Fetoproteins / Q000032:analysis
D000509:alpha-Fetoproteins; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase